SVB Securities, Guggenheim Securities, Cantor and LifeSci Capital are acting as joint bookrunning managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MLTX:
- MoonLake Immunotherapeutics Announces Proposed Underwritten Public Offering
- MoonLake price target doubled to $56 from $28 at SVB Securities
- âStrong’ competitor data sends Acelyrin to the moon
- MoonLake data provide validation for Acelyrin, says Morgan Stanley
- MLTX Skyrockets after Positive Topline Data